Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation CarriersFong, Peter C ; Boss, David S ; Yap, Timothy A ; Tutt, Andrew ; Wu, Peijun ; Mergui-Roelvink, Marja ; Mortimer, Peter ; Swaisland, Helen ; Lau, Alan ; O'Connor, Mark J ; Ashworth, Alan ; Carmichael, James ; Kaye, Stan B ; Schellens, Jan H.M ; de Bono, Johann SThe New England journal of medicine, 2009-07, Vol.361 (2), p.123-134 [Periódico revisado por pares]Waltham, MA: Massachusetts Medical SocietyTexto completo disponível |
|
2 |
Material Type: Artigo
|
Clinical Pharmacokinetics of Therapeutic Monoclonal AntibodiesKeizer, Ron J. ; Huitema, Alwin D. R. ; Schellens, Jan H. M. ; Beijnen, Jos H.Clinical pharmacokinetics, 2010-08, Vol.49 (8), p.493-507 [Periódico revisado por pares]Cham: Springer International PublishingTexto completo disponível |
|
3 |
Material Type: Artigo
|
Piraña and PCluster: A modeling environment and cluster infrastructure for NONMEMKeizer, Ron J ; van Benten, Michel ; Beijnen, Jos H ; Schellens, Jan H.M ; Huitema, Alwin D.RComputer methods and programs in biomedicine, 2011, Vol.101 (1), p.72-79 [Periódico revisado por pares]Kidlington: Elsevier Ireland LtdTexto completo disponível |
|
4 |
Material Type: Artigo
|
A Phase I and Pharmacological Study with Imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a Novel Ruthenium Anticancer AgentRADEMAKER-LAKHAI, Jeany M ; VAN DEN BONGARD, Desiree ; PLUIM, Dick ; BEIJNEN, Jos H ; SCHELLENS, Jan H. MClinical cancer research, 2004-06, Vol.10 (11), p.3717-3727 [Periódico revisado por pares]Philadelphia, PA: American Association for Cancer ResearchTexto completo disponível |
|
5 |
Material Type: Artigo
|
Relationship between Single Nucleotide Polymorphisms and Haplotypes in DPYD and Toxicity and Efficacy of Capecitabine in Advanced Colorectal CancerDEENEN, Maarten J ; TOL, Jolien ; SCHELLENS, Jan H. M ; CATS, Annemieke ; BURYLO, Artur M ; DOODEMAN, Valerie D ; DE BOER, Anthonius ; VINCENT, Andrew ; GUCHELAAR, Henk-Jan ; SMITS, Paul H. M ; BEIJNEN, Jos H ; PUNT, Cornelis J. AClinical cancer research, 2011-05, Vol.17 (10), p.3455-3468 [Periódico revisado por pares]Philadelphia, PA: American Association for Cancer ResearchTexto completo disponível |
|
6 |
Material Type: Artigo
|
P‐glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxelHendrikx, Jeroen J.M.A. ; Lagas, Jurjen S. ; Rosing, Hilde ; Schellens, Jan H.M. ; Beijnen, Jos H. ; Schinkel, Alfred H.International journal of cancer, 2013-05, Vol.132 (10), p.2439-2447 [Periódico revisado por pares]Hoboken: Wiley Subscription Services, Inc., A Wiley CompanyTexto completo disponível |
|
7 |
Material Type: Artigo
|
Systematic review of biomarkers to monitor therapeutic response in leishmaniasisKip, Anke E ; Balasegaram, Manica ; Beijnen, Jos H ; Schellens, Jan H M ; de Vries, Peter J ; Dorlo, Thomas P CAntimicrobial agents and chemotherapy, 2015-01, Vol.59 (1), p.1-14 [Periódico revisado por pares]United States: American Society for MicrobiologyTexto completo disponível |
|
8 |
Material Type: Artigo
|
Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapyLeijen, Suzanne ; Burgers, Sjaak A. ; Baas, Paul ; Pluim, Dick ; Tibben, Matthijs ; van Werkhoven, Erik ; Alessio, Enzo ; Sava, Gianni ; Beijnen, Jos H. ; Schellens, Jan H. M.Investigational new drugs, 2015-02, Vol.33 (1), p.201-214 [Periódico revisado por pares]Boston: Springer USTexto completo disponível |
|
9 |
Material Type: Artigo
|
Clinical proteomics in breast cancer: a reviewGast, Marie-Christine W ; Schellens, Jan H. M ; Beijnen, Jos HBreast cancer research and treatment, 2009-07, Vol.116 (1), p.17-29 [Periódico revisado por pares]Boston: Boston : Springer USTexto completo disponível |
|
10 |
Material Type: Artigo
|
Electrospray Ionization Quadrupole Ion-Mobility Time-of-Flight Mass Spectrometry as a Tool to Distinguish the Lot-to-Lot Heterogeneity in N-Glycosylation Profile of the Therapeutic Monoclonal Antibody TrastuzumabDamen, Carola W.N. ; Chen, Weibin ; Chakraborty, Asish B. ; van Oosterhout, Mike ; Mazzeo, Jeffrey R. ; Gebler, John C. ; Schellens, Jan H.M. ; Rosing, Hilde ; Beijnen, Jos H.Journal of the American Society for Mass Spectrometry, 2009-11, Vol.20 (11), p.2021-2033 [Periódico revisado por pares]New York: Elsevier IncTexto completo disponível |